Goldman Sachs’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$31.7M Sell
1,468,488
-710,282
-33% -$15.3M ﹤0.01% 1439
2025
Q1
$36.2M Sell
2,178,770
-701,694
-24% -$11.7M 0.01% 1261
2024
Q4
$52.9M Buy
2,880,464
+1,121,605
+64% +$20.6M 0.01% 1045
2024
Q3
$27.1M Buy
1,758,859
+417,915
+31% +$6.43M ﹤0.01% 1500
2024
Q2
$21.8M Buy
1,340,944
+613,039
+84% +$9.96M ﹤0.01% 1545
2024
Q1
$13.5M Sell
727,905
-76,265
-9% -$1.41M ﹤0.01% 1826
2023
Q4
$25.2M Buy
804,170
+85,545
+12% +$2.68M ﹤0.01% 1395
2023
Q3
$15M Sell
718,625
-554,799
-44% -$11.6M ﹤0.01% 1695
2023
Q2
$30.5M Buy
1,273,424
+293,686
+30% +$7.03M 0.01% 1255
2023
Q1
$18.4M Sell
979,738
-10,885
-1% -$205K ﹤0.01% 1575
2022
Q4
$15.8M Sell
990,623
-189,775
-16% -$3.02M ﹤0.01% 1791
2022
Q3
$19.3M Buy
1,180,398
+122,904
+12% +$2.01M ﹤0.01% 1623
2022
Q2
$14.9M Sell
1,057,494
-46,883
-4% -$661K ﹤0.01% 1820
2022
Q1
$26.7M Sell
1,104,377
-77,546
-7% -$1.88M 0.01% 1522
2021
Q4
$27.6M Buy
1,181,923
+355,077
+43% +$8.29M 0.01% 1535
2021
Q3
$13.7M Buy
826,846
+265,531
+47% +$4.41M ﹤0.01% 2016
2021
Q2
$13.7M Sell
561,315
-480,934
-46% -$11.7M ﹤0.01% 2017
2021
Q1
$26.9M Buy
1,042,249
+31,159
+3% +$804K 0.01% 1465
2020
Q4
$54.1M Buy
1,011,090
+51,023
+5% +$2.73M 0.01% 913
2020
Q3
$39.6M Sell
960,067
-140,479
-13% -$5.79M 0.01% 1009
2020
Q2
$53.3M Sell
1,100,546
-295,931
-21% -$14.3M 0.02% 815
2020
Q1
$59M Buy
1,396,477
+142,920
+11% +$6.04M 0.02% 691
2019
Q4
$53.6M Buy
1,253,557
+2,181
+0.2% +$93.3K 0.01% 973
2019
Q3
$45M Sell
1,251,376
-377,611
-23% -$13.6M 0.01% 1045
2019
Q2
$43.5M Sell
1,628,987
-304,158
-16% -$8.13M 0.01% 1094
2019
Q1
$51.9M Sell
1,933,145
-418,767
-18% -$11.2M 0.02% 986
2018
Q4
$38M Buy
2,351,912
+1,074,005
+84% +$17.4M 0.01% 1126
2018
Q3
$26.5M Buy
1,277,907
+535,024
+72% +$11.1M 0.01% 1482
2018
Q2
$11.3M Sell
742,883
-540,163
-42% -$8.25M ﹤0.01% 1938
2018
Q1
$28.8M Buy
1,283,046
+92,122
+8% +$2.07M 0.01% 1343
2017
Q4
$35.9M Sell
1,190,924
-629,354
-35% -$18.9M 0.01% 1252
2017
Q3
$68.6M Sell
1,820,278
-87,973
-5% -$3.31M 0.02% 902
2017
Q2
$53.2M Buy
1,908,251
+785,352
+70% +$21.9M 0.01% 992
2017
Q1
$38.6M Sell
1,122,899
-421,359
-27% -$14.5M 0.01% 1152
2016
Q4
$44.5M Buy
1,544,258
+365,067
+31% +$10.5M 0.01% 1059
2016
Q3
$37.5M Buy
1,179,191
+846,830
+255% +$26.9M 0.01% 1134
2016
Q2
$10.8M Buy
332,361
+28,093
+9% +$912K ﹤0.01% 1713
2016
Q1
$8.51M Buy
304,268
+181,489
+148% +$5.07M ﹤0.01% 1817
2015
Q4
$4.38M Buy
122,779
+34,292
+39% +$1.22M ﹤0.01% 2118
2015
Q3
$2.93M Buy
88,487
+60,201
+213% +$1.99M ﹤0.01% 2322
2015
Q2
$1.18M Sell
28,286
-21,696
-43% -$908K ﹤0.01% 2865
2015
Q1
$1.63M Buy
49,982
+9,970
+25% +$325K ﹤0.01% 2651
2014
Q4
$1.27M Sell
40,012
-191,213
-83% -$6.07M ﹤0.01% 2778
2014
Q3
$5.73M Sell
231,225
-169,022
-42% -$4.18M ﹤0.01% 1896
2014
Q2
$9.04M Buy
400,247
+102,567
+34% +$2.32M ﹤0.01% 1666
2014
Q1
$7.24M Sell
297,680
-201,850
-40% -$4.91M ﹤0.01% 1766
2013
Q4
$12.5M Buy
499,530
+25,953
+5% +$649K ﹤0.01% 1458
2013
Q3
$13M Sell
473,577
-85,070
-15% -$2.34M ﹤0.01% 1324
2013
Q2
$10.1M Buy
+558,647
New +$10.1M ﹤0.01% 1362